These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32623652)

  • 41. Canakinumab in patients with cryopyrin-associated periodic syndrome: an update for clinicians.
    Kuemmerle-Deschner JB; Haug I
    Ther Adv Musculoskelet Dis; 2013 Dec; 5(6):315-29. PubMed ID: 24294305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guidelines for the management and treatment of periodic fever syndromes: Cryopyrin-associated periodic syndromes (cryopyrinopathies - CAPS).
    Terreri MT; Bernardo WM; Len CA; da Silva CA; de Magalhães CM; Sacchetti SB; Ferriani VP; Piotto DG; Cavalcanti Ade S; de Moraes AJ; Sztajnbok FR; de Oliveira SK; Campos LM; Bandeira M; Santos FP; Magalhães CS
    Rev Bras Reumatol Engl Ed; 2016; 56(1):44-51. PubMed ID: 27267333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cryopyrin-associated periodic syndrome].
    Kümmerle-Deschner JB
    Z Rheumatol; 2012 Apr; 71(3):199-208. PubMed ID: 22527214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Similarities and differences in autoinflammatory diseases with urticarial rash, cryopyrin-associated periodic syndrome and Schnitzler syndrome.
    Matsuda T; Takimoto-Ito R; Lipsker D; Kambe N
    Allergol Int; 2023 Jul; 72(3):385-393. PubMed ID: 36906447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS).
    Kuemmerle-Deschner JB; Ozen S; Tyrrell PN; Kone-Paut I; Goldbach-Mansky R; Lachmann H; Blank N; Hoffman HM; Weissbarth-Riedel E; Hugle B; Kallinich T; Gattorno M; Gul A; Ter Haar N; Oswald M; Dedeoglu F; Cantarini L; Benseler SM
    Ann Rheum Dis; 2017 Jun; 76(6):942-947. PubMed ID: 27707729
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Presentation of cryopyrin-associated periodic fever syndrome as chronic, afebrile urticaria in a 12-month-old female.
    Fitzgerald LA; Drissi M; Sepulveda K; Hovland C; Hendrick SJ; Dubrocq G
    Pediatr Dermatol; 2023; 40(3):532-533. PubMed ID: 36382474
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cryopyrin-associated periodic fever syndrome in children: A case-based review.
    Gupta A; Tripathy SK; Phulware RH; Arava S; Bagri NK
    Int J Rheum Dis; 2020 Feb; 23(2):262-270. PubMed ID: 31858722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The genetic and clinical characteristics and effects of Canakinumab on cryopyrin-associated periodic syndrome: a large pediatric cohort study from China.
    Shu Z; Zhang Y; Han T; Li Y; Piao Y; Sun F; Ma J; Mo W; Sun J; Chan KW; Yang W; Lau YL; Mao H
    Front Immunol; 2023; 14():1267933. PubMed ID: 37809096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cryopyrin-associated periodic syndromes: background and therapeutics.
    Kubota T; Koike R
    Mod Rheumatol; 2010 Jun; 20(3):213-21. PubMed ID: 20140476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age.
    Caorsi R; Lepore L; Zulian F; Alessio M; Stabile A; Insalaco A; Finetti M; Battagliese A; Martini G; Bibalo C; Martini A; Gattorno M
    Arthritis Res Ther; 2013 Feb; 15(1):R33. PubMed ID: 23442610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Knock-In Mouse Model of Cryopyrin-Associated Periodic Syndromes.
    Bertoni A; Prigione I; Chiesa S; Ceccherini I; Gattorno M; Rubartelli A
    Methods Mol Biol; 2023; 2696():281-297. PubMed ID: 37578730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges.
    Kuemmerle-Deschner JB; Verma D; Endres T; Broderick L; de Jesus AA; Hofer F; Blank N; Krause K; Rietschel C; Horneff G; Aksentijevich I; Lohse P; Goldbach-Mansky R; Hoffman HM; Benseler SM
    Arthritis Rheumatol; 2017 Nov; 69(11):2233-2240. PubMed ID: 28692792
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dosage Considerations for Canakinumab in Children With Periodic Fever Syndromes.
    Zhuang L; Chen J; Yu J; Marathe A; Sahajwalla C; Borigini M; Maynard J; Burckart GJ; Wang Y
    Clin Pharmacol Ther; 2019 Sep; 106(3):557-567. PubMed ID: 30447083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Novel Mutation in the Pyrin Domain of the NOD-like Receptor Family Pyrin Domain Containing Protein 3 in Muckle-Wells Syndrome.
    Hu J; Zhu Y; Zhang JZ; Zhang RG; Li HM
    Chin Med J (Engl); 2017 Mar; 130(5):586-593. PubMed ID: 28229991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A three-generation Muckle-Wells syndrome family: Detailed family history, physical examination, and inter-departmental collaboration.
    Kato D; Yamaide F; Kida I; Takasaki Y; Sato N; Nakano T; Yamaide A; Shimojo N
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):282-287. PubMed ID: 34979568
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes.
    Kuemmerle-Deschner JB; Hachulla E; Cartwright R; Hawkins PN; Tran TA; Bader-Meunier B; Hoyer J; Gattorno M; Gul A; Smith J; Leslie KS; Jiménez S; Morell-Dubois S; Davis N; Patel N; Widmer A; Preiss R; Lachmann HJ
    Ann Rheum Dis; 2011 Dec; 70(12):2095-102. PubMed ID: 21859692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS).
    Toker O; Hashkes PJ
    Biologics; 2010 May; 4():131-8. PubMed ID: 20531965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired cytokine responses in patients with cryopyrin-associated periodic syndrome (CAPS).
    Haverkamp MH; van de Vosse E; Goldbach-Mansky R; Holland SM
    Clin Exp Immunol; 2014 Sep; 177(3):720-31. PubMed ID: 24773462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-world safety and effectiveness of canakinumab in patients with cryopyrin-associated periodic fever syndrome: a long-term observational study in Japan.
    Hosono K; Kato C; Sasajima T
    Clin Exp Rheumatol; 2022 Sep; 40(8):1543-1553. PubMed ID: 36106540
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased quality of life and societal impact of cryopyrin-associated periodic syndrome treated with canakinumab: a questionnaire based cohort study.
    Mulders-Manders CM; Kanters TA; van Daele PLA; Hoppenreijs E; Legger GE; van Laar JAM; Simon A; Hakkaart-van Roijen L
    Orphanet J Rare Dis; 2018 Apr; 13(1):59. PubMed ID: 29678136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.